Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

ReNeuron receives U.K. approval for ground-breaking clinical trial of ReN-001 in ischemic stroke

Jan. 20, 2009

Alzheimer's Drug Discovery Foundation provides grant to Edunn Biotechnology

Jan. 20, 2009

AstraZeneca imparts novel metabotropic glutamate receptor oxadiazole ligands

Jan. 20, 2009

Peptimmune grants Novartis exclusive option to license PI-2301 for MS

Jan. 19, 2009

Scientists at Janssen describe new analgesic FAAH inhibitors in recent patent

Jan. 19, 2009

Novel mgluR5 positive allosteric modulators developed at GSK for schizophrenia

Jan. 19, 2009

Analgesic calcium channel alpha2-delta subreceptor ligands claimed by Kyowa Hakko Kirin

Jan. 19, 2009

Copernicus and the University of Kentucky to collaborate on DNA therapy for PD

Jan. 19, 2009

Benefit seen with multi-herbal product Yi-Gan San in vascular dementia patients

Jan. 19, 2009

Intra-Cellular reports top-line phase II ITI-007 results in insomnia

Jan. 19, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...